Citations (32)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Yachao Ren, Bingchuan Yuan, Shenghua Hou, Yilei Sui, Tinghui Yang, Meilin Lv, Yulong Zhou, Hui Yu, Sen Li, Haisheng Peng, Naidan Chang & Yang Liu. (2021) Delivery of RGD-modified liposome as a targeted colorectal carcinoma therapy and its autophagy mechanism. Journal of Drug Targeting 29:8, pages 863-874.
Read now
Read now
Lumin Liao, Bohong Cen, Guoxian Li, Yuanyi Wei, Zhen Wang, Wen Huang, Shuai He, Yawei Yuan & Aimin Ji. (2021) A bivalent cyclic RGD–siRNA conjugate enhances the antitumor effect of apatinib via co-inhibiting VEGFR2 in non-small cell lung cancer xenografts. Drug Delivery 28:1, pages 1432-1442.
Read now
Read now
Manmohan S. Jangdey, Chanchal Deep Kaur & Swarnlata Saraf. (2019) Efficacy of Concanavalin-A conjugated nanotransfersomal gel of apigenin for enhanced targeted delivery of UV induced skin malignant melanoma. Artificial Cells, Nanomedicine, and Biotechnology 47:1, pages 904-916.
Read now
Read now
Shiwei Niu, David H. Bremner, Junzi Wu, Jianrong Wu, Haijun Wang, Heyu Li, Qianqian Qian, Hong Zheng & Limin Zhu. (2018) l-Peptide functionalized dual-responsive nanoparticles for controlled paclitaxel release and enhanced apoptosis in breast cancer cells. Drug Delivery 25:1, pages 1275-1288.
Read now
Read now
Meng Wu, Hongyun Zhao, Liang Guo, Yiru Wang, Jiao Song, Xueli Zhao, Chongyan Li, Lan Hao, Dong Wang & Jie Tang. (2018) Ultrasound-mediated nanobubble destruction (UMND) facilitates the delivery of A10-3.2 aptamer targeted and siRNA-loaded cationic nanobubbles for therapy of prostate cancer. Drug Delivery 25:1, pages 226-240.
Read now
Read now
Junpeng Nie, Wei Cheng, Yunmei Peng, Gan Liu, Yuhan Chen, Xusheng Wang, Chaoyu Liang, Wei Tao, Yinping Wei, Xiaowei Zeng & Lin Mei. (2017) Co-delivery of docetaxel and bortezomib based on a targeting nanoplatform for enhancing cancer chemotherapy effects. Drug Delivery 24:1, pages 1124-1138.
Read now
Read now
Articles from other publishers (26)
Haichao Zhu, Hong Luo, Ruilong Chang, Yifan Yang, Dingkang Liu, Yue Ji, Hai Qin, Haibo Rong & Jun Yin. (2023) Protein-based delivery systems for RNA delivery. Journal of Controlled Release 363, pages 253-274.
Crossref
Crossref
Jong Won Lee, Man Kyu Shim, Hyosuk Kim, Hochung Jang, Yuhan Lee & Sun Hwa Kim. (2023) RNAi therapies: Expanding applications for extrahepatic diseases and overcoming delivery challenges. Advanced Drug Delivery Reviews 201, pages 115073.
Crossref
Crossref
Etikala Amulya, Anupama Sikder, Ganesh Vambhurkar, Saurabh Shah, Dharmendra Kumar Khatri, Rajeev Singh Raghuvanshi, Shashi Bala Singh & Saurabh Srivastava. (2023) Nanomedicine based strategies for oligonucleotide traversion across the blood–brain barrier. Journal of Controlled Release 354, pages 554-571.
Crossref
Crossref
L.V. Kostryukova, Yu.A. Tereshkina, E.G. Tikhonova, M.A. Sanzhakov, D.V. Bobrova & Yu.Yu. Khudoklinova. (2022) Study of the efficiency of cellular accumulation of doxorubicin supplied with a targeted delivery system based on phospholipid nanoparticles with integrin-directed peptide. Biomeditsinskaya Khimiya 68:6, pages 437-443.
Crossref
Crossref
Jong Won Lee, Jiwon Choi, Yeonho Choi, Kwangmeyung Kim, Yoosoo Yang, Sun Hwa Kim, Hong Yeol Yoon & Ick Chan Kwon. (2022) Molecularly engineered siRNA conjugates for tumor-targeted RNAi therapy. Journal of Controlled Release 351, pages 713-726.
Crossref
Crossref
Zhi Peng, Shiwei Niu, Li Gui, Xiaolin Kuang, Fan Li, Bo Chen, Wanting Li, Jianlin Jiao, Sheng Lu & Di Lu. (2022) Wnt3a loaded deformable hydrogel acts as a 3D culture platform for in situ recruitment of stem cells to efficiently repair bone defects via the asymmetric division. Chemical Engineering Journal 442, pages 136163.
Crossref
Crossref
Xin-Qi Teng, Jian Qu, Guo-Hua Li, Hai-Hui Zhuang & Qiang Qu. (2022) Small Interfering RNA for Gliomas Treatment: Overcoming Hurdles in Delivery. Frontiers in Cell and Developmental Biology 10.
Crossref
Crossref
Ming Zhang, You‐wen Wang, Yuan‐zhang Zhu & Xiao‐ling Gu. (2021) Discovery of quality control ingredients in burdock root by combining anti‐tumor effects and UHPLC–QqQ–MS/MS. Biomedical Chromatography 35:11.
Crossref
Crossref
Shabnam Tarvirdipour, Michal Skowicki, Cora-Ann Schoenenberger & Cornelia G. Palivan. (2021) Peptide-Assisted Nucleic Acid Delivery Systems on the Rise. International Journal of Molecular Sciences 22:16, pages 9092.
Crossref
Crossref
Md Abdus Subhan, Sara Aly Attia & Vladimir P. Torchilin. (2021) Advances in siRNA delivery strategies for the treatment of MDR cancer. Life Sciences 274, pages 119337.
Crossref
Crossref
Takanori Kubo, Yoshio Nishimura, Yuichiro Sato, Kazuyoshi Yanagihara & Toshio Seyama. (2020) Sixteen Different Types of Lipid-Conjugated siRNAs Containing Saturated and Unsaturated Fatty Acids and Exhibiting Enhanced RNAi Potency. ACS Chemical Biology 16:1, pages 150-164.
Crossref
Crossref
Prabhjeet Singh, Aditi Singh, Shruti Shah, Jalpa Vataliya, Anupama Mittal & Deepak Chitkara. (2020) RNA Interference Nanotherapeutics for Treatment of Glioblastoma Multiforme. Molecular Pharmaceutics 17:11, pages 4040-4066.
Crossref
Crossref
Elena de las Heras, Ester Boix‐Garriga, Francesca Bryden, Montserrat Agut, Margarita Mora, M. Lluïsa Sagristá, Ross W. Boyle, Norbert Lange & Santi Nonell. (2020) c(RGDfK)‐ and ZnTriMPyP‐Bound Polymeric Nanocarriers for Tumor‐Targeted Photodynamic Therapy. Photochemistry and Photobiology 96:3, pages 570-580.
Crossref
Crossref
Zengjun Fang, Shaobin Pan, Peng Gao, Huagang Sheng, Lingjun Li, Lei Shi, Yongqing Zhang & Xiaoqing Cai. (2020) Stimuli-responsive charge-reversal nano drug delivery system: The promising targeted carriers for tumor therapy. International Journal of Pharmaceutics 575, pages 118841.
Crossref
Crossref
Sharmin Seraj, Young Jae Cho, Jeong-Won Lee & Hyung Jun Ahn. (2020) Cytoplasmic expression of EGFR shRNA using a modified T7 autogene-based hybrid mRNA/DNA system induces long-term EGFR silencing and prolongs antitumor effects. Biochemical Pharmacology 171, pages 113735.
Crossref
Crossref
James C. Cummings, Haiwen Zhang & Andrew Jakymiw. (2019) Peptide carriers to the rescue: overcoming the barriers to siRNA delivery for cancer treatment. Translational Research 214, pages 92-104.
Crossref
Crossref
Qiaobei Pan, Jing Zhang, Xiang Li, Qian Zou, Peng Zhang, Ying Luo & Yi Jin. (2019) Construction of novel multifunctional luminescent nanoparticles based on DNA bridging and their inhibitory effect on tumor growth. RSC Advances 9:26, pages 15042-15052.
Crossref
Crossref
Anna M. Krichevsky & Erik J. Uhlmann. (2019) Oligonucleotide Therapeutics as a New Class of Drugs for Malignant Brain Tumors: Targeting mRNAs, Regulatory RNAs, Mutations, Combinations, and Beyond. Neurotherapeutics 16:2, pages 319-347.
Crossref
Crossref
Bruno M. D. C. Godinho, Andrew H. Coles & Anastasia Khvorova. 2019. Advances in Nucleic Acid Therapeutics. Advances in Nucleic Acid Therapeutics
206
232
.
Akash Chandela & Yoshihito Ueno. (2019) Systemic Delivery of Small Interfering RNA Therapeutics: Obstacles and Advances. Reviews in Agricultural Science 7:0, pages 10-28.
Crossref
Crossref
Bohong Cen, Yuanyi Wei, Wen Huang, Muzhou Teng, Shuai He, Jianlong Li, Wei Wang, Guolin He, Xin Bai, Xiaoxia Liu, Yawei Yuan, Xinghua Pan & Aimin Ji. (2018) An Efficient Bivalent Cyclic RGD-PIK3CB siRNA Conjugate for Specific Targeted Therapy against Glioblastoma In Vitro and In Vivo. Molecular Therapy - Nucleic Acids 13, pages 220-232.
Crossref
Crossref
Galia Tiram, Shiran Ferber, Paula Ofek, Anat Eldar-Boock, Dikla Ben-Shushan, Eilam Yeini, Adva Krivitsky, Roni Blatt, Nava Almog, Jack Henkin, Orit Amsalem, Eylon Yavin, Gadi Cohen, Philip Lazarovici, Joo Sang Lee, Eytan Ruppin, Michael Milyavsky, Rachel Grossman, Zvi Ram, Marcelo Calderón, Rainer Haag & Ronit Satchi-Fainaro. (2018) Reverting the molecular fingerprint of tumor dormancy as a therapeutic strategy for glioblastoma. The FASEB Journal 32:11, pages 5835-5850.
Crossref
Crossref
Bohong Cen, Wenjie Liao, Zhen Wang, Linyuan Gao, Yuanyi Wei, Wen Huang, Shuai He, Wei Wang, Xiaoxia Liu, Xinghua Pan & Aimin Ji. (2018) Gelofusine Attenuates Tubulointerstitial Injury Induced by cRGD-Conjugated siRNA by Regulating the TLR3 Signaling Pathway. Molecular Therapy - Nucleic Acids 11, pages 300-311.
Crossref
Crossref
Érika Cosset, Sten Ilmjärv, Valérie Dutoit, Kathryn Elliott, Tami von Schalscha, Maria F. Camargo, Alexander Reiss, Toshiro Moroishi, Laetitia Seguin, German Gomez, Jung-Soon Moo, Olivier Preynat-Seauve, Karl-Heinz Krause, Hervé Chneiweiss, Jann N. Sarkaria, Kun-Liang Guan, Pierre-Yves Dietrich, Sara M. Weis, Paul S. Mischel & David A. Cheresh. (2017) Glut3 Addiction Is a Druggable Vulnerability for a Molecularly Defined Subpopulation of Glioblastoma. Cancer Cell 32:6, pages 856-868.e5.
Crossref
Crossref
Eunice L. Lozada-Delgado, Nilmary Grafals-Ruiz & Pablo E. Vivas-Mejía. (2017) RNA interference for glioblastoma therapy: Innovation ladder from the bench to clinical trials. Life Sciences 188, pages 26-36.
Crossref
Crossref
Zhong-Hao Ji, Jian Chen, Wei Gao, Jin-Yu Zhang, Fu-Shi Quan, Jin-Ping Hu, Bao Yuan & Wen-Zhi Ren. (2017) Cutaneous transcriptome analysis in NIH hairless mice. PLOS ONE 12:8, pages e0182463.
Crossref
Crossref